10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $589,174 | -93.8% | 14,283 | -91.7% | 0.01% | -94.7% |
| Q2 2023 | $9,552,660 | +410943.9% | 171,072 | +310.7% | 0.11% | +216.7% |
| Q1 2023 | $2,324 | +78.9% | 41,655 | +16.9% | 0.04% | +38.5% |
| Q4 2022 | $1,299 | -100.0% | 35,647 | -57.1% | 0.03% | -73.7% |
| Q2 2022 | $3,756,000 | +24.0% | 82,997 | +108.4% | 0.10% | +39.4% |
| Q1 2022 | $3,030,000 | +518.4% | 39,832 | +1493.3% | 0.07% | +688.9% |
| Q2 2021 | $490,000 | -32.4% | 2,500 | -51.2% | 0.01% | -55.0% |
| Q4 2020 | $725,000 | -88.7% | 5,122 | -90.0% | 0.02% | -92.8% |
| Q3 2020 | $6,396,000 | +1016.2% | 51,296 | +351.2% | 0.28% | +1290.0% |
| Q3 2019 | $573,000 | – | 11,368 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |